Navigation Links
Craneware Announces Fiscal Year-End Results
Date:9/8/2009

ATLANTA, Sept. 8 /PRNewswire/ -- Craneware, Inc. (AIM: CRW.L), a leader in sustainable financial improvement solutions for the U.S. healthcare market, is pleased to announce results for the year ended June 30, 2009.

Financial Highlights

  • Record levels of contracted sales in the year totaling $43.2m (FY08: $25.7m), 68% up from the previous year, contributing to:
    • 23% increase in revenues to $23.0m (FY08: $18.7m)
    • 51% increase in future revenues under contract to $60.1m (FY08:$39.9m)
  • Profit before share based payments, depreciation and amortization increased 29% to $5.8m (FY08: $4.5m)
  • Profit before taxation increased by 40% to $5.9m (FY08: $4.2m)
  • Cash position increased 24% to $26.1m (FY08 $21.1m)
  • Basic EPS increased to $0.18 (FY08: $0.14) and diluted to $0.17 (FY08: $0.13)
  • Final dividend proposed of 2.9p (4.77 cents) per share giving a total dividend for the year of 4.7p (7.43 cents) per share (FY08: 3.1p (4.96 cents) per share)

Operational Highlights

  • New product lines contributed $10.1m (23%) to total contracted sales during the year
  • Extended market reach through partnership deals with Premier, Amerinet and Perot
  • Signed significant reseller agreement with McKesson Corporation post year-end
  • Accelerated investment in sales and marketing activities
  • Proposed U.S. Healthcare reforms trend toward increased regulation and new market opportunities

Keith Neilson, CEO of Craneware, commented, "The U.S. healthcare system is currently undergoing an unprecedented level of change and public scrutiny. This combined with the global economic downturn means healthcare organizations are experiencing extraordinary levels of fiscal and legislative pressure. Craneware continues to invest in the development and deployment of software to help manage these pressures and we believe that our market leading position and reputation within the industry, combined with our strong business fundamentals, leaves us well positioned to serve this growing demand.

"The signing of a significant value-added reseller agreement with McKesson Corporation, the world's largest healthcare services company, at the beginning of this new fiscal year has given us a strong start. The agreement sees McKesson integrate Craneware's Chargemster Toolkit(R) software with their next generation hospital information system (HIS), Horizon Enyterprise Revenue Management(TM) as part of their ongoing legacy system replacement and upgrading program. This new agreement, combined with a growing Craneware sales pipeline and the launch of further products by the end of the current year, gives us confidence we are on track to continue our history of significant growth in the year ahead."

About Craneware

Craneware (AIM: CRW.L) partners with healthcare organizations to improve returns, increase productivity and manage risk, driving sustainable financial and operational performance improvements using market-led revenue management solutions. By enhancing revenue capture processes, Craneware SaaS solutions allow those organizations to optimize reimbursement, improve operational efficiency, and support compliance. Visit craneware.com.

A full copy of the Company's Year-End Results can be found on Craneware's Web site at http://craneware.com. In the Investors area of the Web site, click on Financial Reports.

This document does not constitute an offer to sell or issue or the solicitation of an offer to buy or subscribe for Ordinary Shares in any jurisdiction in which such offer or solicitation is unlawful.


'/>"/>
SOURCE Craneware, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Craneware to Highlight Best Practices for Optimizing Revenue Capture Processes in Two Seminar Presentations during HFMAs 2009 ANI: The Healthcare Finance Conference
2. Craneware Supports Hospitals Compliance and Upfront Collections with Accurate Estimates
3. Craneware Appoints New Non-Executive Director
4. Craneware to Offer Financial Performance Solutions to Hospitals and Healthcare Providers Through Premier, the Largest U.S. Healthcare Alliance
5. Craneware and St. Joseph to Present Revenue Enhancement Success Story at HIMSS
6. Craneware Announces Half-Year Results
7. Cochlear Americas Announces FDA Approval of the Nucleus(R) 5 System, the Newest and Most Advanced Cochlear Implant System
8. Medizone International, Inc. Announces OTCBB Listing
9. PPJ Enterprise Announces New Acquisition
10. Migraine Research Foundation Announces Winners of 2009 Research Grants
11. Asymchem Announces Fall Process Symposium Confirmed List of Speakers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Doctor C ... it attended the January ECRM trade show to continue the marketing and distribution of ... C supplement, known for providing 400 percent better absorption than traditional vitamin C supplements. ...
(Date:1/20/2017)... ... January 20, 2017 , ... International Protein, a company based out of ... it attended the January ECRM trade show in Hilton Head, SC. , International ... determined to create a line of products that would elevate her fitness regime. At ...
(Date:1/20/2017)... ... ... “Mary Magdalene: Grace is Greater than Sin”: a unique and memorable piece of ... Magdalene: Grace is Greater than Sin” is the creation of published author, Brenda Roberts, ... who had little knowledge of the female characters portrayed in the Holy Bible. ...
(Date:1/20/2017)... Farmville, NC (PRWEB) , ... January 20, 2017 ... ... the vPEP ® Oscillating Positive Expiratory Pressure (OPEP) device, was featured in ... article by Doug Pursley, MEd, RRT-ACCS, FAARC, “Analysis of Three Oscillating Positive ...
(Date:1/20/2017)... ... ... “The Land of More and More”: a brilliant story for children ... the simple and achievable answer. “The Land of More and More” is the creation ... in Angola, Indiana where he works with the children’s ministry department. , Michael ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase ... The global anti-obesity drugs market is expected to ... the forecast period and CAGR of 38.7% in the second half ... a CAGR of 32.8% from 2016 to 2027. The market is ... $24,063 million in 2027. ...
(Date:1/19/2017)... -- Accuray Incorporated (Nasdaq: ARAY ) announced ... set the bar for excellence in customer satisfaction. The ... rating among radiation treatment delivery systems in the U.S., ... Briefing™. The most recent ratings trend also shows Accuray ... for 11 of the past 12 quarters. ...
(Date:1/19/2017)... LONDON , January 19, 2017 ... Grothey ; European Oncology & Haematology, 2016;12(Suppl 2):3-8; ... ... http://photos.prnewswire.com/prnh/20151014/276718LOGO) Published recently in ... the peer-reviewed journal from touchONCOLOGY, an article by ...
Breaking Medicine Technology: